This study examined the potential effects of CD38 expression and increased extracellular ADO production in B-cell lymphoma on various hematological and clinical parameters and their possible connection to the PD-1/PD-L1 axis. This evidence concerns the gene CD38 and B-cell non-Hodgkin lymphoma.